WuXi AppTec is pleased to announce the distinguished speakers and agenda for WuXi Global Forum 2023, which will take place on January 10, 2023 from 1:00-6:00PM PST at Hilton San Francisco Union Square in concurrent with the J.P. Morgan Healthcare Conference.
The theme of this year’s forum is B.O.L.D. We will reflect on the state of innovation and highlight our industry’s notable advances in tackling innovation challenges to build an impactful future for patients: Breaking Barriers, Opening New Horizons, Leading Next Generation, and Delivering on the Promise for Patients.
WuXi Global Forum 2023 is complimentary and by invitation.
AGENDA (The time below is PM, Pacific Standard Time)
For the full program and each speaker’s bio, please click HERE
1:00 Onsite Check-in and Networking
1:30 Welcome
Hui Cai, Program Chair and Vice President, WuXi AppTec
1:35 Opening Remarks
Minzhang Chen, Co-CEO, WuXi AppTec
1:45 State of Innovation 2023
Todd Golub, Director, Broad Institute of MIT & Harvard
John Ngai, Director, NIH BRAIN Initiative
Vijay Pande, General Partner, Andreessen Horowitz
Aviv Regev, Head, Genentech Research and Early Development
Michael Severino, CEO, Tessera Therapeutics; CEO-Partner, Flagship Pioneering
Session Leader: Mathai Mammen, Executive Vice President of R&D, Johnson & Johnson Pharmaceuticals (in transition)
Spotlight on B.O.L.D.
2:30 Breaking Barriers: Druggability Redefined
Ros Deegan, CEO, OMass Therapeutics
Dan Nomura, Professor of Chemical Biology and Molecular Therapeutics, University of California, Berkeley
Nancy Pryer, CSO, Ambagon Therapeutics
Lance Stewart, Chief Strategy and Operations Officer, Institute for Protein Design, University of Washington
Session Leader: C. Simone Fishburn, VP & Editor in Chief, BioCentury Inc.
3:10 Opening New Horizons: Spotlight on RNA Therapeutics
Tom Barnes, CEO, Orna Therapeutics
John Mendlein, Chairman, Laronde; Executive Partner, Flagship Pioneering
Romesh Subramanian, CEO, Ascidian Therapeutics
Michelle Werner, CEO, Alltrna; CEO-Partner, Flagship Pioneering
Session Leader: Nina Kjellson, General Partner, Canaan
3:50 Leading Next Generation of Cell and Gene Therapies
Ken Drazan, Chairman, CEO, Co-Founder, ArsenalBio
Keith Gottesdiener, President & CEO, Prime Medicine
Laura Shawver, President & CEO, Capstan Therapeutics
Catherine Stehman-Breen, CEO, Chroma Medicine
Session Leader: Edward Hu, Vice Chairman, Global Chief Investment Officer, WuXi AppTec
4:30 Delivering on the Promise for Patients
Giulio Draetta, SVP & CSO, MD Anderson Cancer Center
Stephen Hauser, Director, UCSF Weill Institute for Neurosciences; Professor, Department of Neurology, University of California, San Francisco
Joseph Wu, Director of Stanford Cardiovascular Institute; President-Elect of American Heart Association
Session Leader: Christiana Bardon, Co-Managing Partner of BioImpact Capital, an MPM affiliate
5:05 Building an Impactful Future
Niranjan Bose, Managing Director, Health & Life Sciences, Gates Ventures
Juergen Eckhardt, SVP & Head of Leaps by Bayer
Sofia Ioannidou, Partner, Andera Partners
Carol Suh, Partner, ARCH Venture Partners
Sze-Wee Tan, Assistant Chief Executive, Innovation and Enterprise Group, Singapore Agency for Science, Technology and Research (A*STAR)
Session Leader: Michal Preminger, Regional Head, Johnson & Johnson Innovation East North America
5:50 Closing Remarks
Steve Yang, Co-CEO, WuXi AppTec
6:00 Networking Reception
